Supernus Pharmaceuticals Cash Flow Statement (2011-2026) | SUPN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
23.73M21.56M2.44M25.62M7.82M1.75M25.51M16.92M-0.83M-16.01M1.14M0.12M19.90M38.54M15.33M-11.83M22.50M-45.12M-4.13M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
5.48M4.03M4.04M4.03M4.30M4.99M4.26M6.31M6.09M7.92M6.45M5.90M6.55M7.67M7.63M8.07M7.51M7.83M9.65M8.48M
Deferred Taxes (Quarter)
0.52M1.57M-4.51M-13.01M-3.05M-2.51M-7.76M-0.43M-5.55M-9.27M-10.46M-5.48M-8.12M-6.47M-0.07M-3.99M-7.16M-2.65M19.00M5.92M
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)
-7.70M0.08M8.00M0.03M0.74M0.49M-0.01M-2.46M0.79M-0.46M34.61M2.60M-4.36M-1.02M-37.63M3.34M-6.08M2.39M
Asset Writedowns and Impairment (Quarter)
20.20M0.73M1.29M-0.03M-1.99M0.55M0.92M-0.24M-1.23M1.81M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
46.27M-4.11M48.76M4.30M71.12M13.84M27.56M49.13M-18.87M35.88M44.96M38.40M35.62M53.52M44.41M30.60M58.53M-61.66M19.86M66.52M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.67M-1.53M-1.26M0.36M-1.43M-2.15M-0.02M1.06M-0.14M-0.07M-0.73M-1.89M0.36M-0.97M7.95M1.07M0.03M0.92M5.95M0.19M
Amortization of Deferred Charges (Quarter)
4.30M4.40M4.50M0.53M0.50M0.53M0.53M0.53M
Depreciation & Amortization (CF) (Quarter)
6.62M6.67M12.71M21.36M21.56M21.77M20.85M20.60M20.73M21.86M21.68M20.75M20.72M20.10M18.84M20.38M21.36M24.81M25.02M26.13M
Change in Working Capital
Change in Receivables (Quarter)
10.20M-3.75M3.48M-3.81M12.90M5.87M1.41M-21.97M-4.39M5.21M2.39M3.58M4.76M-7.09M-3.33M3.56M-4.81M7.13M16.42M-5.62M
Change in Inventory (Quarter)
6.90M1.38M5.25M2.47M-4.31M8.15M11.55M1.85M3.98M-6.91M-5.03M-1.99M-6.03M-4.60M-3.19M-4.73M-4.89M12.94M4.18M0.10M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
44.86M-41.55M12.32M7.46M5.58M12.71M-44.91M-10.55M7.71M13.65M-8.20M10.02M-12.79M17.62M-29.86M3.94M8.27M-36.29M16.47M0.05M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-4.65M-1.06M-0.81M-1.23M-9.21M0.34M28.20M-20.41M-7.80M7.52M-0.73M1.75M10.81M-7.37M2.50M11.14M6.91M12.43M
Investing Activities
Capital Expenditures (Quarter)
0.55M-0.27M0.30M-0.17M0.28M0.16M0.15M-0.04M0.25M0.06M0.20M0.21M0.33M0.46M0.13M0.43M
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
34.27M68.70M377.96M28.93M92.19M52.08M17.55M240.06M60.45M34.78M35.60M142.32M75.45M148.12M132.98M156.20M110.40M468.56M39.32M59.22M
Cash from Investing Activities (Quarter)
-80.89M-5.70M76.13M-69.99M-15.68M-82.23M-48.77M239.78M60.30M34.63M-65.98M-51.62M-48.59M-77.01M-12.64M37.32M-30.61M48.71M-51.31M-19.22M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
2.75M1.32M-136.74M-22.03M2.27M6.46M2.83M80.17M-478.92M-0.23M1.09M1.57M1.66M3.08M5.89M-21.40M0.94M21.07M8.53M9.12M
Additional items
Change in Cash (Quarter)
-31.87M-8.49M-11.85M-87.72M57.71M-61.94M-18.37M369.08M-437.49M70.28M-19.93M-11.65M-11.31M-20.42M37.66M46.52M28.86M8.11M-22.92M56.42M
Free Cash Flow (Quarter)
46.27M-4.11M48.76M3.75M71.39M13.54M27.73M48.85M-19.03M35.73M44.99M38.15M35.56M53.32M44.19M30.27M58.08M-61.79M19.43M66.52M
Net Cash Flow (Quarter)
-31.87M-8.49M-11.85M-87.72M57.71M-61.94M-18.37M369.08M-437.49M70.28M-19.93M-11.65M-11.31M-20.42M37.66M46.52M28.86M8.11M-22.92M56.42M